Ichor Life Sciences is driven by a mission to transform healthcare by pioneering advancements in preclinical research and pharmacology, aiming to foster a new era of pharmaceuticals. The company operates as a fully integrated contract research organization (CRO) headquartered in Syracuse, NY, with complete preclinical research and development capabilities. This facility setup enables Ichor to assist clients across the entire drug discovery and development pipeline, from protein discovery to comprehensive pharmaceutical data generation, all supported by rigorous publication efforts in high-impact journals.

Though now a major player with multiple commercial facilities, Ichor’s beginnings were modest, reflecting its commitment to growth and innovation. Founded with a vision to significantly impact healthcare, Ichor has expanded its footprint while staying focused on advancing aging research and providing specialized services for drug R&D.

Previously known as Ichor Therapeutics until 2021.